GRI Bio (GRI) Accumulated Expenses (2020 - 2026)

GRI Bio's Accumulated Expenses history runs 7 years deep, the most recent figure standing at $433000.0 for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 68.35% year-over-year to $433000.0; the TTM figure through Mar 2026 stood at $433000.0 (down 68.35% YoY), while the FY2025 annual figure was $750000.0, up 8.54% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $433000.0, down from $750000.0 in the prior quarter.
• The five-year high for Accumulated Expenses was $1.4 million in Q3 2025, with the low at $36000.0 in Q4 2022.
• The 5-year median for Accumulated Expenses is $960000.0 (2025), against an average of $929941.2.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses sank 97.48% in 2022, then soared 3427.78% in 2023.
• GRI Bio's Accumulated Expenses stood at $36000.0 in 2022, then jumped by 3427.78% to $1.3 million in 2023, then plunged by 45.59% to $691000.0 in 2024, then grew by 8.54% to $750000.0 in 2025, then sank by 42.27% to $433000.0 in 2026.
• Business Quant data shows GRI's Accumulated Expenses at $433000.0 in Q1 2026, $750000.0 in Q4 2025, and $1.4 million in Q3 2025.